|

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

RECRUITINGSponsored by Istituti Clinici Scientifici Maugeri SpA
Actively Recruiting
SponsorIstituti Clinici Scientifici Maugeri SpA
Started2019-06-15
Est. completion2025-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this observational study is to learn about the impact of the different types of pain and of the domains involved in the autonomic disorders of inpatients and outpatients diagnosed with Parkinson disease (PD) and multiple system atrophy (MSA) admitted to Istituti Clinici Scientifici Maugeri Centers. The main aims are: Evaluate the prevalence of pain and characterize it in Parkinson's disease and atypical parkinsonisms (MSA) Evaluate the effect of rehabilitation on pain and autonomic symptoms Evaluate the prevalence of autonomic symptoms in Parkinson's disease and atypical parkinsonisms (MSA) Assess the impact of pain and autonomic symptoms on quality of life. Participants will perform neurological examination, rehabilitation program and clinical scales. Researchers will compare the two groups of patients (PD and MSA) and the effect of the rehabilitation on pain, autonomic symptoms and quality of life.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Clinical diagnosis of Parkinson's Disease or Multiple System Atrophy according to current international criteria (Gilman S et al, 2008; Postuma RB et al. 2015).
* Mini-Mental State Examination score at least 10

Exclusion Criteria:

* vascular or pharmacological parkinsonism
* diabetes mellitus
* hepatic or renal dysmetabolism,
* hypothyroidism or hyperthyroidism
* assumption of potentially neurotoxic drugs

Conditions3

Multiple System AtrophyParkinson DiseaseParkinson's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.